Error: Could not add to watchlist. X

Antibe Therapeutics Inc

+ Watchlist
ATE:CN
Venture
0.11
CAD
0.01
8.33%
As of 13:16:36 ET on 07/28/2015.
Open
0.11
Day Range
0.11 - 0.12
Volume
268,400
Previous Close
0.12
52Wk Range
0.04 - 0.60
1 Yr Return
-80.36%
Open
0.11
Day Range
0.11 - 0.12
Volume
268,400
Previous Close
0.12
52Wk Range
0.04 - 0.60
1 Yr Return
-80.36%
YTD Return
-78.00%
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-0.12
Market Cap (m CAD)
5.959
Shares Outstanding (m)
49.655
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Antibe Therapeutics Inc designs and develops new pharmaceuticals. The Company focuses on diseases characterized by inflammation, pain and/or vascular dysfunction.
ADDRESS
15 Prince Arthur Avenue
Toronto, ON M5R 1B2
Canada
PHONE
-
  • Walter M Macnee "Walt"
    Chairman
  • Daniel Legault "Dan"
    Chief Executive Officer
  • Michael Bumby
    Chief Financial Officer
  • John L Wallace
    Chief Scientific Officer/Founder
  • David Vaughan
    Chief Development Officer
Show More